The drug industry is facing one of the largest patent cliffs in recent history. Will that mean dealmaking at the annual J.P.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Boehringer and Eli Lilly have started a large-scale trial of their diabetes drug Jardiance in acute heart ... “Unlike chronic heart failure, there is no established therapy available that ...

The EMPACT-MI trial found that giving Boehringer Ingelheim and Eli Lilly’s SGLT2 drug Jardiance ... 6,500 patients, and there were some signs of efficacy with Jardiance, including a significant ...

Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates worldwide. Explore more here.

More than 110,000 North Carolinians are projected to benefit from a $2,000 annual cap on out-of-pocket costs for covered prescription drugs for Medicare Part D participants.

After years of delays and debate, 2024 was the year when several health initiatives started to move forward. And advocates ...

Pill for type 2 diabetes may control diabetic eye disease Boehringer Ingelheim and Eli Lilly’s oral diabetes drug Jardiance may keep diabetic eye disease from worsening in patients with type 2 ...

To receive the full newsletter in your inbox for free sign up here, opens new tab) The Johnson & Johnson (JNJ.N), opens new tab drug Darzalex ... patient had received Jardiance, a pill from ...

“There are many people on this drug, and they will benefit by another generic version of it,” Dr. Harlan Krumholz, a cardiologist at Yale University and Yale New Haven Hospital, told CNN by emai ...